Hospital Circular 03/2007
Date Issued: 22 February 2007
Distribution: Highly Specialised Drugs Program
Subject: To advise hospitals of changes to the Highly Specialised Drugs Program, effective 1 March 2007.
We have had recent advice from the Commonwealth Government of changes to the Highly Specialised Drugs Program, effective 1 March 2007.
Deleted Items
Nelfinavir Mesylate |
||||
| 6231Y | Oral powder, 50mg(base)/g, 144g | 1 | Viracept | RO |
Saquinavir |
||||
| 6248W | Soft gelatin capsule 200mg | 180 | Fortovase | RO |
Items discontinued by the manufacturer.
Amended Restrictions
Iloprost Trometamol |
||||
| 6456T | Solution for inhalation 20mcg (base) in 2ml | 30 | Ventavis | SC |
| Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website. | ||||
Bosentan Monohydrate |
||||
| 6429J | Tablet 62.5mg (base) | 60 | Tracleer | AT |
| 6430K | Tablet 125mg (base) | 60 | Tracleer | AT |
| Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website. | ||||
Infliximab |
||||
| 6397Q 6448J 6496X |
Powder for IV infusion 100mg | 1 | Remicade | SH |
| Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website. | ||||
Epoprostenol Sodium |
||||
| 6477X | Powder for IV infusion 500mcg (base) with 1 vial diluent 50ml | 1 | Flolan | GK |
| 6478Y | Powder for IV infusion 1.5mg (base) with 2 vials diluent 50ml | 1 | Flolan | GK |
| Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website. | ||||
Added Item
Sildenafil Citrate |
||||
| 9605M | Tablet 20mg | 90 | Revatio | PF |
| Full prescribing criteria for all items available at the Commonwealth/State Highly Specialised Drugs Program Guidelines website. | ||||
Changes notified by hospital circular will be updated in the Guidelines on the Commonwealth/State Highly Specialised Drugs Program Guidelines website and the claim form amended.
Dr Jennifer King
Director, Programs
Metropolitan Health & Aged Care Services
